Ganirelix acetate is a synthetic peptide compound that acts as a competitive antagonist of gonadotropin-releasing hormone (GnRH). It is primarily used as a pharmaceutical raw material in the manufacturing of injectable formulations for controlled ovarian stimulation in assisted reproduction protocols.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ganirelix?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ganirelix acetate
pharmaceutical raw material
Ganirelix
pharmaceutical raw material
Cetrorelix acetate
pharmaceutical raw material
Cetrorelix
pharmaceutical raw material
Abarelix
pharmaceutical raw material
Iturelix
pharmaceutical raw material
Elagolix sodium
pharmaceutical raw material
Linzagolix
pharmaceutical raw material
The international HS code for Ganirelix (CAS 124904-93-4) is 2937.19.
2937.19
2937 19 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]amino]-4-methylpentanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
GJNXBNATEDXMAK-PFLSVRRQSA-N
CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC
Sourcing Ganirelix?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.